My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Wipro surges on share buyback proposal
Jul 17,2017

The announcement was made after market hours on Friday, 14 July 2017.

Meanwhile, the S&P BSE Sensex was up 83.03 points or 0.26% at 32,103.78.

On the BSE, 1.56 lakh shares were traded on the counter so far as against the average daily volumes of 2.33 lakh shares in the past one quarter. The stock had hit a high of Rs 273.90 and a low of Rs 264.70 so far during the day. The stock had hit a 52-week high of Rs 288.75 on 13 July 2016 and a 52-week low of Rs 205 on 9 November 2016.

The stock had underperformed the market over the past one month till 14 July 2017, advancing 1.35% compared with the Sensexs 2.78% rise. The stock had also underperformed the market over the past one quarter, gaining 4.89% as against the Sensexs 8.69% rise. The scrip had also underperformed the market over the past one year, sliding 9.06% as against the Sensexs 14.6% rise.

The large-cap company has equity capital of Rs 973.23 crore. Face value per share is Rs 2.

Wipros consolidated net profit rose 7.2% to Rs 2267 crore on 2.16% rise in net sales to Rs 14062 crore in Q4 March 2017 over Q3 December 2016.

Wipro is a leading information technology, consulting and business process services company that delivers solutions to enable its clients do business better.

Powered by Capital Market - Live News

Alkem Laboratories gets rosier after USFDA clears facility
Jul 17,2017

The announcement was made by the company after market hours on Friday, 14 July 2017.

Meanwhile, the S&P BSE Sensex was up 68.80 points or 0.22% at 32,090.05.

On the BSE, 553 shares were traded on the counter so far as against the average daily volumes of 3,328 shares in the past one quarter. The stock had hit a high of Rs 1,844 and a low of Rs 1,821.85 so far during the day.

Alkem Laboratories said that no Form 483 was issued by United States Food & Drug Administration (USFDA) after conducting an inspection at the companys Bioequivalence facility located at Taloja, Navi Mumbai from 10 July 2017 to 14 July 2017.

The stock had dropped 3.12% in four sessions to Rs 1,787.90 on 14 July 2017 from a close of Rs 1,845.65 on 10 July 2017.

Alkem Laboratories consolidated net profit rose 58.3% to Rs 136.96 crore on 9% rise in net sales to Rs 1251.4 crore in Q4 March 2017 over Q4 March 2016.

Alkem Laboratories is a pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.

Powered by Capital Market - Live News

Cadila gains after FDA nod for sclerosis treatment drug
Jul 17,2017

The announcement was made after market hours on Friday, 14 July 2017.

Meanwhile, the S&P BSE Sensex was up 57.96 points or 0.18% at 32,078.71.

On the BSE, 9,336 shares were traded on the counter so far as against the average daily volumes of 1.43 lakh shares in the past one quarter. The stock had hit a high of Rs 543.20 and a low of Rs 539 so far during the day. The stock had hit a record high of Rs 558 on 12 June 2017 and a 52-week low of Rs 329.95 on 26 December 2016.

The stock had underperformed the market over the past one month till 14 July 2017, advancing 0.25% compared with the Sensexs 2.78% rise. The stock had, however, outperformed the market over the past one quarter, gaining 16.95% as against the Sensexs 8.69% rise. The scrip had also outperformed the market over the past one year, advancing 45.49% as against the Sensexs 14.6% rise.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Rs 1.

Cadila Healthcare announced that it has received the tentative approval from the United States Food and Drug Administration (USFDA) to market Fingolimod Capsules, 0.5 mg. The drug is an immunomodulating drug, mostly used for treating multiple sclerosis and will be produced at the groups formulations manufacturing facility at the Pharma SEZ, in Ahmedabad. The sales of Fingolimod Capsules is estimated at $2.1 billion as per IMS Health data.

The group now has more than 120 approvals and has so far filed over 300 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04.

Cadila Healthcares consolidated net profit fell 32.2% to Rs 385.5 crore on 6.5% rise in net sales to Rs 2417.50 crore in Q4 March 2017 over Q4 March 2016.

Cadila Healthcare is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

GP Petroleums slips on profit taking
Jul 14,2017

Meanwhile, the S&P BSE Sensex was down 12.66 points or 0.04% at 32,024.72. The S&P BSE Small-Cap index declined 56.85 points or 0.36% at 15,906.72.

On the BSE, 21,000 shares were traded on the counter so far as against the average daily volumes of 32,609 shares in the past one quarter. The stock had hit a high of Rs 101.90 and a low of Rs 96.85 so far during the day. The stock had hit a record high of Rs 103.60 on 21 April 2017 and a 52-week low of Rs 55 on 2 August 2016.

The stock had outperformed the market over the past one month till 13 July 2017, surging 12.44% compared with the Sensexs 3% rise. The stock had, however, underperformed the market over the past one quarter, gaining 8.72% as against the Sensexs 8.74% rise. The scrip had also outperformed the market over the past one year, jumping 69.51% as against the Sensexs 15.18% rise.

The small-cap company has equity capital of Rs 25.49 crore. Face value per share is Rs 5.

Shares of GP Petroleums had surged 10.21% in the preceding three trading sessions to settle at Rs 100.35 yesterday, 13 July 2017, from its closing of Rs 91.05 on 10 July 2017.

GP Petroleums net profit rose 4.5% to Rs 5.79 crore on 16.4% decline in net sales to Rs 127.91 crore in Q4 March 2017 over Q4 March 2016.

GP Petroleums is engaged in the production of lubricating oils, greases, and other products from crude oil. The companys segments are Lubricants and Trading.

Powered by Capital Market - Live News

GVK Power advances after completing stake sale in Bangalore airport
Jul 14,2017

The announcement was made after market hours yesterday, 13 July 2017.

Meanwhile, the S&P BSE Sensex was down 29.24 points or 0.09% at 32,008.14. The S&P BSE Small-Cap index declined 61.95 points or 0.39% at 15,901.62.

On the BSE, 16.02 lakh shares were traded on the counter so far as against the average daily volumes of 15.43 lakh shares in the past one quarter. The stock had hit a high of Rs 7.78 and a low of Rs 7.36 so far during the day. The stock had hit a 52-week high of Rs 9.22 on 3 July 2017 and a 52-week low of Rs 5.05 on 25 May 2017.

The stock had outperformed the market over the past one month till 13 July 2017, surging 19.9% compared with the Sensexs 3% rise. The stock had also outperformed the market over the past one quarter, advancing 22.11% as against the Sensexs 8.74% rise. The scrip had, however, underperformed the market over the past one year, gaining 7.05% as against the Sensexs 15.18% rise.

The small-cap company has equity capital of Rs 157.92 crore. Face value per share is Rs 1.

GVK Power and Infrastructure (GVK Power) announced the successful completion of the sale of its residual stake of 10% in Bangalore International Airport (BIAL), held through its subsidiary, Bangalore Airport Infrastructure Developers (BAIDPL) to Fairfax India Holdings Corporation (Fairfax India) for a consideration of Rs 1290 crore (approximately $200 million).

In March 2017, GVK closed an agreement which was signed during March 2016 with Fairfax India to sell a 33% stake in BIAL. It had retained a 10% stake and the management of BIAL. Subsequently, in June 2017, GVK announced its decision to conclude the sale of this 10% residual stake to Fairfax India, subject to necessary consents and approvals.

Dr. G V K Reddy, Founder Chairman & Managing Director of GVK while speaking on the development said that since deleveraging is currently the managements top priority, it decided to part ways with BIAL. However, the Airports sector will continue to be a core focus area for GVK, he said.

Reddy added that the management will now focus on Mumbai as well as the Navi Mumbai airport for which the company has won the bid and also on selectively evaluating privatization opportunities. Capacity optimization and real estate development will now be the priority areas for the existing Mumbai airport, added Dr. Reddy.

GVK Power and Infrastructure reported net loss of Rs 205.85 crore in Q4 March 2017, higher than net loss of Rs 105.59 crore in Q4 March 2016. Net sales rose 4.1% to Rs 7.10 crore in Q4 March 2017 over Q4 March 2016.

GVK is a leading conglomerate with presence across energy, airports, transportation, hospitality and life sciences.

Powered by Capital Market - Live News

Biocon leads gainers in A group
Jul 14,2017

Biocon jumped 9.25% to Rs 400.55 at 13:43 IST after the company said that the US drug regulatory committee recommended approval of Mylan N.V. and Biocons proposed biosimilar trastuzumab. The stock topped the gainers in the BSEs A group. On the BSE, 17.33 lakh shares were traded on the counter so far as against the average daily volumes of 6.88 lakh shares in the past two weeks.

Religare Enterprises surged 7.27% at Rs 115.80. The stock was second biggest gainer in A group. On the BSE, 5.08 lakh shares were traded on the counter so far as against the average daily volumes of 1.95 lakh shares in the past two weeks.

Aurobindo Pharma advanced 4.38% to Rs 735.40. The stock was third biggest gainer in A group. On the BSE, 7.37 lakh shares were traded on the counter so far as against the average daily volumes of 2.47 lakh shares in the past two weeks.

Jubilant FoodWorks gained 4.13% at Rs 1,156.60. The stock was fourth biggest gainer in A group. On the BSE, 82,000 shares were traded on the counter so far as against the average daily volumes of 73,000 shares in the past two weeks.

CESC rose 3.29% to Rs 895.35. The stock was fifth biggest gainer in A group. On the BSE, 29,000 shares were traded on the counter so far as against the average daily volumes of 22,000 shares in the past two weeks.

Powered by Capital Market - Live News

Ramco rallies 11.6% in two sessions
Jul 14,2017

Meanwhile, the S&P BSE Sensex was down 21.34 points or 0.07% at 32,016.04. The S&P BSE Small-Cap index declined 41.94 points or 0.26% at 15,921.63.

On the BSE, 78,000 shares were traded on the counter so far as against the average daily volumes of 7,620 shares in the past one quarter. The stock had hit a high of Rs 390 and a low of Rs 345.50 so far during the day. The stock had hit a 52-week high of Rs 706 on 11 July 2016 and a 52-week low of Rs 286 on 15 December 2016.

The stock had outperformed the market over the past one month till 13 July 2017, surging 9.07% compared with the Sensexs 3% rise. The stock had, however, underperformed the market over the past one quarter, declining 10.66% as against the Sensexs 8.74% rise. The scrip had also underperformed the market over the past one year, sliding 50.18% as against the Sensexs 15.18% rise.

The small-cap company has equity capital of Rs 30.44 crore. Face value per share is Rs 10.

Shares of Ramco Systems have jumped 11.61% in two trading sessions to its ruling market price, from its close of Rs 336.50 on 12 July 2017 after the company announced during market hours yesterday, 13 July 2017 that it has won an order win from China Southern Airlines General Aviation (CSAGA) for integrating its organization-wide maintenance and engineering operations. The stock had gained 2.62% to settle at Rs 345.30 yesterday, 13 July 2017.

CSAGA, which operates Asias largest fleet of Sikorsky helicopters, will implement Ramco Aviation Maintenance & Engineering Suite 5.8, enabling its staff across China to automate and manage fleet data in real time.

Ramco Aviation Suite V5.8 is a powerful enterprise application that covers the entire spectrum of maintenance operations both for the civil and the military helicoptersn++from maintenance planning to line, hangar, shop and engine maintenance, reliability and engineering, and technical records.

On consolidated basis, Ramco Systems net profit surged 160.38% to Rs 8.02 crore on 1.32% growth in net sales to Rs 114.31 crore in Q4 March 2017 over Q3 December 2016.

Ramco Systems is a fast growing enterprise software player disrupting the market with its multi-tenanted cloud and mobile-based enterprise software in the area of HCM and Global Payroll, ERP and M&E MRO for Aviation.

Powered by Capital Market - Live News

Majesco declines after recent sharp rally
Jul 14,2017

Meanwhile, the S&P BSE Sensex was down 18.86 points, or 0.06% at 32,018.52. The S&P BSE Small-cap index was down 47.39 points, or 0.3% at 15,916.18.

On the BSE, 44,000 shares were traded on the counter so far as against the average daily volumes of 21,797 shares in the past one quarter. The stock had hit a high of Rs 368.60 and a low of Rs 351 so far during the day. The stock had hit a 52-week high of Rs 575 on 25 July 2016 and a 52-week low of Rs 300 on 10 July 2017.

The stock had outperformed the market over the past one month till 13 July 2017, advancing 11.32% compared with the Sensexs 3% rise. The scrip had, however, underperformed the market over the past one quarter declining 6.7% as against the Sensexs 8.74% rise. The scrip had also underperformed the market over the past one year declining 28.79% as against the Sensexs 15.18% rise.

The small-cap company has equity capital of Rs 11.73 crore. Face value per share is Rs 5.

Shares of Majesco had rallied 20.59% in the preceding four trading sessions to settle at Rs 366.35 yesterday, 13 July 2017, from its close of Rs 303.80 on 7 July 2017.

Majesco announced on 11 July 2017 that its insurance subsidiary Majesco USA informed that its client Shelter Insurance is live on Majesco billing for its new brand, say insurance, focused on delivering a digital auto insurance product that is transparent, simple and convenient.

Majescos consolidated net profit fell 49.9% to Rs 2.54 crore on 7.16% decrease in net sales to Rs 187.78 crore in Q4 March 2017 over Q3 December 2016.

Majesco enables insurance business transformation for insurance customers worldwide by providing solutions which include software, consulting and services.

Powered by Capital Market - Live News

Volumes jump at Fortune Financial Services (India) counter
Jul 14,2017

Fortune Financial Services (India) clocked volume of 3.72 lakh shares by 12:36 IST on BSE, a 132.15-times surge over two-week average daily volume of 3,000 shares. The stock rose 6.98% to Rs 344.75.

Nava Bharat Ventures notched up volume of 8.28 lakh shares, a 16.13-fold surge over two-week average daily volume of 51,000 shares. The stock rose 3.75% to Rs 139.80.

TV18 Broadcast saw volume of 76 lakh shares, a 10.50-fold surge over two-week average daily volume of 7.24 lakh shares. The stock rose 2.69% to Rs 42.

Praj Industries clocked volume of 6.28 lakh shares, a 9.72-fold surge over two-week average daily volume of 65,000 shares. The stock rose 6.67% to Rs 82.40.

Videocon Industries saw volume of 33.17 lakh shares, a 6.60-fold rise over two-week average daily volume of 5.03 lakh shares. The stock hit a lower circuit limit of 5% at Rs 30.40.

Powered by Capital Market - Live News

Pricol gains after acquisition
Jul 14,2017

The announcement was made after market hours yesterday, 13 July 2017.

Meanwhile, the S&P BSE Sensex was down 20.33 points, or 0.06% to 32,017.05.

On the BSE, 2.85 lakh shares were traded in the counter so far, compared with average daily volumes of 41,367 shares in the past one quarter. The stock had hit a high of Rs 95 and a low of Rs 91.10 so far during the day. The stock hit a record high of Rs 115.35 on 10 February 2017. The stock hit a record low of Rs 75.75 on 23 May 2017.

The stock had outperformed the market over the past one month till 13 July 2017, rising 13.42% compared with 2.83% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, rising 1.29% as against Sensexs 8.74% rise.

The small-cap company has equity capital of Rs 9.48 crore. Face value per share is Re 1.

Automotive components manufacturer Pricol has signed binding agreements to acquire 100% of the wiping systems business of Ashok Piramal groups PMP Auto Components. The acquisition would be undertaken by Pricol through its wholly-owned subsidiaries. The transaction will be funded by a combination of internal accruals and external debt. The transaction would be earnings per share (EPS) accretive to the shareholders of Pricol and the profitability is expected to further improve upon integration of the business with Pricol.

PMP had acquired this business in 2008 from Magna and is presently running manufacturing facilities in Czech Republic, Mexico and India. The business is supplying wiper motors to global automotive customers including VW, Fiat, John Deere, Skoda, Audi, Seat and has a turnover of around Rs 250 crore currently with a confirmed order book and revenue visibility of more than Rs 450 crore in the financial year ending March 2020.

The acquisition will help Pricol diversify its product offerings and provide access to manufacturing facilities in Europe and North America, where it currently does not have a footprint, helping it cement its status as a global supplier. Additionally, with this acquisition, Pricol will increase its presence with passenger vehicles customers diversifying revenue streams and opening up multiple cross selling opportunities.

Pricol also expects to realize substantial synergies within the first couple of years to further boost the financial performance of the business. Pricols focus as an auto component supplier and experience in low cost production and sourcing can be leveraged by the target businesses for realizing cost savings in sourcing raw materials and reducing manufacturing overheads. Joint research and development (R&D) is also expected to reduce product development costs.

The transaction is subject to customary closing conditions and the parties to the transaction are bound by standard confidentiality obligations.

Net profit of Pricol declined 14.62% to Rs 5.43 crore on 818.76% surge in net sales to Rs 258.63 crore in Q4 March 2017 over Q4 March 2016.

Pricol offers auto components for motor vehicles, motorcycles and three wheelers.

Powered by Capital Market - Live News

Biocon hits record high
Jul 14,2017

The announcement was made before market hours today, 14 July 2017.

Meanwhile, the S&P BSE Sensex was down 66.49 points or 0.21% at 31,970.89.

On the BSE, 14.14 lakh shares were traded on the counter so far as against the average daily volumes of 2.28 lakh shares in the past one quarter. The stock had hit a high of Rs 404 so far during the day, which is a record high. The stock hit a low of Rs 385 so far during the day. The stock had hit a 52-week low of Rs 229.66 on 17 July 2016.

The stock had outperformed the market over the past one month till 13 July 2017, advancing 7.61% compared with the Sensexs 3% rise. The stock had, however, underperformed the market over the past one quarter, gaining 0.22% as against the Sensexs 8.74% rise. The scrip had outperformed the market over the past one year, surging 51.76% as against the Sensexs 15.18% rise.

The large-cap company has equity capital of Rs 300 crore. Face value per share is Rs 5.

Mylan N.V. and Biocon announced that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval of the companies proposed biosimilar trastuzumab. The committee voted 16-0 in support of eligible indications of the reference product, Herceptin, which include HER2-positive breast cancer in the metastatic and adjuvant settings.

Mylan and Biocons proposed biosimilar trastuzumab also is under review by regulatory authorities in Australia, Canada, Europe and several emerging markets.

On consolidated basis, net profit of Biocon declined 61.7% to Rs 127.50 crore on 1.5% decline in net sales to Rs 919.20 crore in Q4 March 2017 over Q4 March 2016.

Biocon is Indias largest and fully-integrated, innovation-led biopharmaceutical company.

Powered by Capital Market - Live News

Dilip Buildcon declines after recent sharp rally
Jul 14,2017

Meanwhile, the S&P BSE Sensex was down 113.07 points, or 0.35% at 31,924.31. The S&P BSE Mid-cap Index was down 32.32 points, or 0.21% at 15,121.22.

On the BSE, 33,000 shares were traded on the counter so far as against the average daily volumes of 62,696 shares in the past one quarter. The stock had hit a high of Rs 549 and a low of Rs 518 so far during the day. The stock had hit a record high of Rs 549.25 on 13 July 2017 and a 52-week low of Rs 178.60 on 9 November 2016.

The stock had outperformed the market over the past one month till 13 July 2017, advancing 20.91% compared with the Sensexs 3% rise. The scrip had also outperformed the market over the past one quarter gaining 46.69% as against the Sensexs 8.74% rise.

The mid-cap company has equity capital of Rs 136.77 crore. Face value per share is Rs 10.

Shares of Dilip Buildcon had rallied 19.58% in the preceding five trading sessions to settle at Rs 543.85 yesterday, 13 July 2017, from its close of Rs 454.80 on 6 July 2017.

Dilip Buildcons net profit jumped 222.5% to Rs 195.77 crore on 28.8% increase in net sales to Rs 1732.30 crore in Q4 March 2017 over Q4 March 2016.

Dilip Buildcon is a road-focused engineering procurement construction (EPC) contractor. The company develops infrastructure across the country in diverse areas such as roads & bridges, water sanitation & sewage, irrigation, industrial, commercial & residential buildings.

Powered by Capital Market - Live News

Satin Creditcare drops on profit booking
Jul 14,2017

Meanwhile, the S&P BSE Sensex was down 94.84 points or 0.3% at 31,942.54. The S&P BSE Small-Cap index fell 78.40 points or 0.49% at 15,885.17.

On the BSE, 7,586 shares were traded on the counter so far as against the average daily volumes of 31,180 shares in the past one quarter. The stock had hit a high of Rs 330.10 and a low of Rs 321 so far during the day. The stock had hit a record high of Rs 716.70 on 28 July 2016 and a record low of Rs 243.55 on 12 June 2017.

The stock had outperformed the market over the past one month till 13 July 2017, advancing 13.7% compared with the Sensexs 3% rise. The stock had, however, underperformed the market over the past one quarter, declining 3.42% as against the Sensexs 8.74% rise. The scrip had also underperformed the market over the past one year, sliding 30.12% as against the Sensexs 15.18% rise.

The small-cap company has equity capital of Rs 39.77 crore. Face value per share is Rs 10.

Shares of Satin Creditcare Network had jumped 17.37% in the preceding seven trading sessions to settle at Rs 333.70 yesterday, 13 July 2017, from its close of Rs 284.30 on 4 July 2017.

On consolidated basis, Satin Creditcare Network reported net loss of Rs 43.11 crore in Q4 March 2017 as against net profit of Rs 24.93 crore in Q4 March 2016. Total income declined 78.1% to Rs 175.22 crore in Q4 March 2017 over Q4 March 2016.

Satin Creditcare Network is one of the leading microfinance companies with a strong presence in North India.

Powered by Capital Market - Live News

Six stocks drop ex-dividend
Jul 14,2017

Meanwhile, the S&P BSE Sensex was down 34.42 points or 0.11% at 32,002.96.

GlaxoSmithKline Pharmaceuticals fell 1.52% to Rs 2,543.65 as the stock turned ex-dividend today, 14 July 2017, for dividend of Rs 30 per share for the year ended 31 March 2017. Before turning ex-dividend, the stock offered a dividend yield of 1.16% based on the closing price of Rs 2,582.95 on BSE yesterday, 13 July 2017.

GIC Housing Finance lost 0.95% to Rs 555 as the stock turned ex-dividend today, 14 July 2017, for dividend of Rs 5 per share for the year ended 31 March 2017. Before turning ex-dividend, the stock offered a dividend yield of 0.89% based on the closing price of Rs 560.35 on BSE yesterday, 13 July 2017.

Alkyl Amines Chemicals fell 0.8% to Rs 418 as the stock turned ex-dividend today, 14 July 2017, for dividend of Rs 5 per share for the year ended 31 March 2017. Before turning ex-dividend, the stock offered a dividend yield of 1.19% based on the closing price of Rs 421.35 on BSE yesterday, 13 July 2017.

HDFC lost 0.66% to Rs 1,645.40 as the stock turned ex-dividend today, 14 July 2017, for final dividend of Rs 15 per share for the year ended 31 March 2017. Before turning ex-dividend, the stock offered a dividend yield of 0.91% based on the closing price of Rs 1,656.30 on BSE yesterday, 13 July 2017.

VIP Industries fell 0.19% to Rs 186.35 as the stock turned ex-dividend today, 14 July 2017, for final dividend of Rs 1.60 per share for the year ended 31 March 2017. Before turning ex-dividend, the stock offered a dividend yield of 0.86% based on the closing price of Rs 186.70 on BSE yesterday, 13 July 2017.

Mahindra & Mahindra Financial Services fell 0.14% to Rs 367.50 as the stock turned ex-dividend today, 14 July 2017, for dividend of Rs 2.40 per share for the year ended 31 March 2017. Before turning ex-dividend, the stock offered a dividend yield of 0.65% based on the closing price of Rs 368 on BSE yesterday, 13 July 2017.

Powered by Capital Market - Live News

Infosys gains after increasing revenue growth guidance for FY 2018
Jul 14,2017

The results are as per International Financial Reporting Standards (IFRS). The result was announced before market hours today, 14 July 2017.

Meanwhile, the S&P BSE Sensex was down 14.63 points or 0.05% at 32,022.75.

On the BSE, 1.92 lakh shares were traded on the counter so far as against the average daily volumes of 2.69 lakh shares in the past one quarter. The stock had hit a high of Rs 1,006.65 and a low of Rs 983.05 so far during the day. The stock had hit a 52-week high of Rs 1,195.05 on 14 July 2016 and a 52-week low of Rs 900.30 on 9 November 2016.

The stock had underperformed the market over the past one month till 13 July 2017, gaining 1.89% compared with the Sensexs 3% rise. The stock had also underperformed the market over the past one quarter, advancing 4.82% as against the Sensexs 8.74% rise. The scrip had also underperformed the market over the past one year, sliding 18.17% as against the Sensexs 15.18% rise.

The large-cap company has equity capital of Rs 1148.47 crore. Face value per share is Rs 5.

Infosys consolidated net profit fell 3.3% to Rs 3483 crore on 0.2% decline in revenue to Rs 17078 crore in Q1 June 2017 over Q4 March 2017.

The company expects its consolidated revenue to grow 7.1%-9.1% in Dollar terms for the financial year ending March 2018 (FY 2018), which was higher than the revenue growth guidance of 6.1%-8.1% issued by the company at the time of announcing Q4 March 2017 earnings.

The company expects its consolidated revenue to grow 3%-5% in Rupee terms for FY 2018, based on the exchange rates as of 30 June 2017. This was higher than the revenue growth guidance of 2.5%-4.5% issued by the company at the time of announcing Q4 March 2017 earnings.

Vishal Sikka, CEO of Infosys said that the companys persistent focus on execution in Q1 was reflected in broad-based performance on multiple fronts - revenue growth, resilient margins despite multiple headwinds, healthy cash generation and overall business results.

The companys COO U B Pravin Rao commented that the company had broad-based growth across geographical and industry segments. The companys initiatives on operational discipline led to record levels of utilization and better realization during the quarter, he added.

Infosys is a global leader in technology services and consulting.

Powered by Capital Market - Live News